تداخلات كالسيتريول

Calcium Supplements Uncontrolled intake of additional calcium-containing preparations should be avoided (see PRECAUTIONS: General ). (نشرة كالسيتريول، التداخلات الدوائية)

Calcium Supplements Uncontrolled intake of additional calcium-containing preparations should be avoided (see PRECAUTIONS: General ). (نشرة كالسيتريول، التداخلات الدوائية)

Calcium Supplements Uncontrolled intake of additional calcium-containing preparations should be avoided (see PRECAUTIONS: General ). (نشرة كالسيتريول، التداخلات الدوائية)

Magnesium-containing preparations (e.g., antacids) and calcitriol should not be used concomitantly in patients on chronic renal dialysis because such use may lead to the development of hypermagnesemia. (نشرة كالسيتريول، التحذيرات)

Magnesium-containing preparations (e.g., antacids) and calcitriol should not be used concomitantly in patients on chronic renal dialysis because such use may lead to the development of hypermagnesemia. (نشرة كالسيتريول، التحذيرات)

Magnesium-containing preparations (e.g., antacids) and calcitriol should not be used concomitantly in patients on chronic renal dialysis because such use may lead to the development of hypermagnesemia. (نشرة كالسيتريول، التحذيرات)

Table 2: Oral drugs that can be administered concomitantly with Ferric Citrate Tablets Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Ferric Citrate Tablets and meals… (نشرة سترات الحديديك، التداخلات الدوائية)

CONTRAINDICATIONS Calcitriol should not be given to patients with hypercalcemia or evidence of vitamin D toxicity. (نشرة كالسيتريول، موانع الاستعمال)

Calcium Supplements Uncontrolled intake of additional calcium-containing preparations should be avoided (see PRECAUTIONS: General ). (نشرة كالسيتريول، التداخلات الدوائية)

Magnesium-containing preparations (e.g., antacids) and calcitriol should not be used concomitantly in patients on chronic renal dialysis because such use may lead to the development of hypermagnesemia. (نشرة كالسيتريول، التحذيرات)

Calcium Supplements Uncontrolled intake of additional calcium-containing preparations should be avoided (see PRECAUTIONS: General ). (نشرة كالسيتريول، التداخلات الدوائية)

Calcium Supplements Uncontrolled intake of additional calcium-containing preparations should be avoided (see PRECAUTIONS: General ). (نشرة كالسيتريول، التداخلات الدوائية)

Calcium Supplements Uncontrolled intake of additional calcium-containing preparations should be avoided (see PRECAUTIONS: General ). (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

The effect of ORLISTAT on the absorption of supplemental vitamin D, vitamin A, and nutritionally-derived vitamin K is not known at this time [see Clinical Pharmacology (12.3) , and Warnings and Precautions (5.1) ] . (نشرة أورليستات، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Instruct patients to take supplemental calcium and vitamin D if their dietary intake is inadequate (see Dosage and Administration [2.3] ) . (نشرة إيباندرونات، التحذيرات والاحتياطات)

Hypercalcemia may be exacerbated by concomitant administration of high doses of calcium-containing preparations, thiazide diuretics, or other vitamin D compounds [see Drug Interactions (7) ] . (نشرة باريكالسيتول، التحذيرات والاحتياطات)

• Electrolyte disorders (e.g., hypophosphatemia, hypokalemia, hypomagnesemia, hypocalcemia): Monitor phosphorus, potassium, magnesium, calcium and vitamin D and adequately supplement as appropriate. (نشرة باميدرونات، التحذيرات والاحتياطات)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

All patients should be instructed about the symptoms of hypocalcemia and the importance of calcium and vitamin D supplementation in maintaining serum calcium levels [see Dosage and Administration ( 2.8 ), Adverse Reactions ( 6.1 ), Patient Counseling Information ( 17 )]. (نشرة حمض الزوليدرونيك، التحذيرات والاحتياطات)

Danazol can increase the calcemic response to synthetic vitamin D analogs in primary hypoparathyroidism. (نشرة دانازول، التداخلات الدوائية)

Hypercalcemia may be exacerbated by concomitant administration of high doses of calcium-containing preparations, thiazide diuretics, or other vitamin D compounds [see Drug Interactions ( 7 )]. (نشرة دوكسيركالسيفيرول، التحذيرات والاحتياطات)

Digitalis Calcitriol dosage must be determined with care in patients undergoing treatment with digitalis, as hypercalcemia in such patients may precipitate cardiac arrhythmias (see PRECAUTIONS: General ). (نشرة كالسيتريول، التداخلات الدوائية)

Monitor calcium levels during therapy, especially in the first weeks of initiating therapy, and adequately supplement all patients with calcium and vitamin D. (نشرة دينوسوماب، التحذيرات والاحتياطات)

Calcium Supplements/Antacids When Risedronate sodium delayed-release was administered following breakfast, the co-administration of a tablet containing 600 mg of elemental calcium and 400 international units vitamin D reduced risedronate bioavailability by approximately 38% [ see Clinical Pharmacology (12.3) ] . (نشرة ريزيدرونات، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

If corrected serum calcium falls below the lower limit of normal or symptoms of hypocalcemia develop, start or increase calcium supplementation (including calcium, calcium-containing phosphate binders, and/or vitamin D sterols or increases in dialysate calcium concentration). (نشرة سيناكالسيت، التحذيرات والاحتياطات)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Other Corticosteroids, doxycycline, estrogens, furosemide, oral contraceptives, paroxetine, quinidine, rifampin, sertraline, theophylline, and vitamin D Drugs whose level is decreased by phenytoin Anticoagulants Apixaban, dabigatran, edoxaban, rivaroxaban Antiepileptic drugs The effect of phenytoin on phenobarbital, valproic acid and sodium valproate serum levels… (نشرة فوسفينيتوين، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Phenytoin/Phenobarbital The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of calcitriol, but may reduce endogenous plasma levels of 25(OH)D 3 by accelerating metabolism. (نشرة كالسيتريول، التداخلات الدوائية)

Phenytoin/Phenobarbital The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of calcitriol, but may reduce endogenous plasma levels of 25(OH)D 3 by accelerating metabolism. (نشرة كالسيتريول، التداخلات الدوائية)

Phenytoin/Phenobarbital The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of calcitriol, but may reduce endogenous plasma levels of 25(OH)D 3 by accelerating metabolism. (نشرة كالسيتريول، التداخلات الدوائية)

Use of Miacalcin injection for the treatment of Paget’s disease or postmenopausal osteoporosis is recommended in conjunction with an adequate intake of calcium and vitamin D [see Dosage and Administration (2.5) ] . (نشرة كالسيتونين السلمون، التحذيرات والاحتياطات)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Drugs That Increase the Risk of Hypercalcemia Increase frequency of monitoring of calcium concentrations in patients taking concomitant Calcium Chloride Injection and other drugs that increase the risk of hypercalcemia (e.g., calcipotriene, estrogen, lithium, parathyroid hormone, teriparatide, thiazide diuretics, Vitamin A, and Vitamin D). (نشرة كلوريد الكالسيوم، التداخلات الدوائية)

DRUG INTERACTIONS Cholestyramine Cholestyramine has been reported to reduce intestinal absorption of fat-soluble vitamins; as such it may impair intestinal absorption of calcitriol (see WARNINGS and PRECAUTIONS: General ). (نشرة كالسيتريول، التداخلات الدوائية)

Reductions in serum endogenous calcitriol concentrations have been observed following the administration of 300 mg/day to 1200 mg/day ketoconazole for a week to healthy men. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

• Routine assessment of 25-hydroxy vitamin D levels prior to the start of aromatase inhibitor treatment should be performed ( 5.2 ). (نشرة إكسيميستان، التحذيرات والاحتياطات)

Other disorders affecting mineral metabolism (such as vitamin D deficiency) should also be effectively treated. (نشرة أليندرونات، التحذيرات والاحتياطات)

Serum parathyroid hormone levels and 1,25 Vitamin D levels were also higher in subjects receiving TDF. (نشرة إمتريسيتابين وريلبيفيرين وتينوفوفير، التحذيرات والاحتياطات)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Serum parathyroid hormone levels and 1,25 Vitamin D levels were also higher in subjects receiving TDF. (نشرة إيفافيرينز ولاميفودين وتينوفوفير، التحذيرات والاحتياطات)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Serum parathyroid hormone levels and 1,25 Vitamin D levels were also higher in subjects receiving VIREAD. (نشرة تينوفوفير، التحذيرات والاحتياطات)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Other Medications Used for the Management of Fanconi Syndrome PROCYSBI can be administered with other electrolyte and mineral replacements necessary for management of Fanconi syndrome, as well as vitamin D and thyroid hormone. (نشرة سيستيامين، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Drugs that may cause hypercalcemia: Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. (نشرة غلوكونات الكالسيوم، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (نشرة كالسيتريول، التداخلات الدوائية)